Michael Gelband’s Evolv Technologies EVLV Stock Holding History

Michael Gelband’s Portfolio EVLV Stock Details EVLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$401K	Sell	69,156 -4,579	-6%	-$28.7K	﹤0.01%	1293
2026 Q1	$446K	Sell	73,735 -155,688	-68%	-$911K	﹤0.01%	1222
2025 Q4	$1.64M	Buy	229,423 +123,099	+116%	+$875K	0.01%	829
2025 Q3	$803K	Buy	106,324 +22,069	+26%	+$161K	0.01%	1038
2025 Q2	$526K	Buy	+84,255	New	+$390K	﹤0.01%	1140
2025 Q1	–	Sell	-37,220	Closed	-$147K	–	1618
2024 Q4	$147K	Buy	+37,220	New	+$131K	﹤0.01%	1386
2022 Q2	–	Sell	-120,014	Closed	-$318K	–	2076
2022 Q1	$318K	Buy	120,014 +35,862	+43%	+$117K	﹤0.01%	1735
2021 Q4	$375K	Buy	+84,152	New	+$472K	﹤0.01%	1564

Other funds holding EVLV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SPCM

Stoic Point Capital Management Palo Alto, California $121M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

DCI

Data Collective IV Palo Alto, California $78.6M AUM 55.41% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Michael Gelband's EVLV Position: Q2 2026 in Review

Michael Gelband reduced its Evolv Technologies (EVLV) stake by 6.2% in Q2 2026, selling an estimated $28.7K and leaving 69,156 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1293.

Michael Gelband first reported a position in EVLV in Q4 2021 and has held it in 8 quarters since. The position peaked at $1.64M in Q4 2025. 259 funds tracked by Wall St. Rank hold EVLV as of Q2 2026.

Michael Gelband held 69,156 shares of Evolv Technologies worth $401K as of Q2 2026.
Michael Gelband sold 4,579 Evolv Technologies shares in Q2 2026, an estimated $28.7K.
Evolv Technologies made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1293 holding.
Michael Gelband first reported a position in Evolv Technologies in Q4 2021 and has held it in 8 quarters since.
Michael Gelband's Evolv Technologies position peaked at $1.64M in Q4 2025.
259 funds tracked by Wall St. Rank held Evolv Technologies as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.